Medimmune Inc

USPTO Trademark & Patent Filings

Trademark applications and grants for Medimmune Inc. Medimmune Inc has 25 trademark applications. The latest application filed is for "CAN CLINICAL ACCESS NOW"

Company Profile

MEDIMMUNE, INC
MedImmune, Inc.
MedImmune, Inc. - Gaithersburg MD
MEDIMMUNE, INC. - Gaithersburg MD
MedImmune, Inc. -

Trademarks Patents

Patent Applications

Patent Application	Date
Methods of treating and preventing RSV, hMPV, and PIV using anti-RSV, anti-hMPV, and anti-PIV antibodies 20100278813 - 12/001458 Young; James F. ; et al.	2010-11-04
Modulators of EphA2 and Ephrin-A1 for the treatment of fibrosis-related disease 20100260749 - 12/185568 Kinch; Michael S. ; et al.	2010-10-14
INTEGRATED APPROACH FOR GENERATING MULTIDOMAIN PROTEIN THERAPEUTICS 20100105873 - 11/993680 Allan; Christian ; et al.	2010-04-29
MODULATION OF ANTIBODY EFFECTOR FUNCTION BY HINGE DOMAIN ENGINEERING 20090221803 - 11/912562 Dall'Acqua; William ; et al.	2009-09-03
Stabilized anti-respiratory syncytial virus (RSV) antibody formulations 20090175883 - 12/075197 Oliver; Cynthia N. ; et al.	2009-07-09

Patent Grants & Applications

Trademark Applications

Mark Image Registration \| Serial	Trademark Application Date
"CAN CLINICAL ACCESS NOW" 77067340	CAN CLINICAL ACCESS NOW 2006-12-19
"CAN" 77067368	CAN 2006-12-19
"ETHYOL CAN PROGRAM" 77067392	ETHYOL CAN PROGRAM 2006-12-19
"PREEMIE SECURITY BLANKET" 78762850	PREEMIE SECURITY BLANKET 2005-11-29
"XEROSTOMIAFACTS" 78716211	XEROSTOMIAFACTS 2005-09-20
"DAZAX" 78692694	DAZAX 2005-08-15
"SYNAGIS LQ" 78405755	SYNAGIS LQ 2004-04-21
"PARTNERS IN FLU PREVENTION" 78195593	PARTNERS IN FLU PREVENTION 2002-12-18
"DAZAX" 76355455	DAZAX 2002-01-04
"SYNAGIS (PALIVIZUMAB) SECURE PLUS+ PROGRAM" 2556152 78053483	SYNAGIS (PALIVIZUMAB) SECURE PLUS+ PROGRAM 2001-03-16
"SYNAGIS SECURE PLUS+ PROGRAM" 2607661 78053523	SYNAGIS SECURE PLUS+ PROGRAM 2001-03-16
"Symbol/Image" 2479354 75886755	Symbol/Image 2000-01-04
"SYNAGIS SECURE PROGRAM" 75791866	SYNAGIS SECURE PROGRAM 1999-09-02
"VITAXIN" 2562777 75691914	VITAXIN 1999-04-26
"SYNAGIS" 75410505	SYNAGIS 1997-12-24
"SYNAGIS" 2248349 75408414	SYNAGIS 1997-12-19
"DAZAX" 75404744	DAZAX 1997-12-12
"NUMAX" 75404778	NUMAX 1997-12-12
"SYNAEGIS" 75379721	SYNAEGIS 1997-10-27
"RESPIGAM" 2050408 75006849	RESPIGAM 1995-10-17
"RESPIGAM" 74433758	RESPIGAM 1993-09-09
"RESPIVIR" 74308366	RESPIVIR 1992-08-24
"RESPIVIR-IV" 74308367	RESPIVIR-IV 1992-08-24
"HYPERMUNE - CMV" 74023093	HYPERMUNE - CMV 1990-01-26
"HYPERMUNE - RSV" 1733923 74023094	HYPERMUNE - RSV 1990-01-26

Company Registrations

NCAGE Code	3WRC6	MEDIMMUNE INC.!DBA MEDIMMUNE ONCOLOGY
CAGE Code	3WRC6	MEDIMMUNE, INC. MEDIMMUNE ONCOLOGY
SEC	0000873591	MEDIMMUNE INC /DE of DELAWARE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.